First Affordable Teriparatide Injection Biosimilar Will Enter the Philippine Market — A Future of Cost-effective Bone Health Treatment
Getmeds, a trusted provider of affordable cancer, hematology, and anesthesia products, is taking a meaningful step forward by offering the most cost-effective teriparatide injection pen biosimilar in the Philippine market. This initiative provides an accessible…
Read More